In the month of June, the MDLinx editors covered a number of interesting conferences in a number of specialties, including neurology, oncology, rheumatology, and endocrinology. Here are some of the studies that were presented at those conferences.
The 2016 Annual Meeting of the Consortium of Multiple Sclerosis Centers was held in Baltimore, MD June 1-4, 2016. The OPERA I and II investigators presented findings on the effect of ocrelizumab (OCR), an anti-CD20+ B cell monoclonal antibody, on specific humoral immunity in two identical phase 3, randomized, double-blind, double-dummy, interferon beta-1a (IFNβ-1a)-controlled trials involving patients with relapsing multiple sclerosis. The article was titled: TreatmentRead More